ACADIA Pharmaceuticals Inc. ACAD
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 976.45M | 956.47M | 851.46M | 819.69M | 847.02M |
| Total Receivables | 178.32M | 166.33M | 148.38M | 148.23M | 139.44M |
| Inventory | 40.36M | 32.37M | 31.57M | 34.67M | 29.10M |
| Prepaid Expenses | 73.31M | 69.37M | 64.60M | 59.53M | 60.87M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.27B | 1.22B | 1.10B | 1.06B | 1.08B |
|
|
|||||
| Total Current Assets | 1.27B | 1.22B | 1.10B | 1.06B | 1.08B |
| Net Property, Plant & Equipment | 85.87M | 86.53M | 60.93M | 54.87M | 53.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 135.48M | 103.45M | 106.17M | 108.89M | 111.62M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 304.37M | 328.38M | 342.12M | 338.32M | 89.35M |
| Total Assets | 1.79B | 1.74B | 1.61B | 1.56B | 1.33B |
|
|
|||||
| Total Accounts Payable | 16.33M | 44.57M | 12.25M | 10.90M | 21.75M |
| Total Accrued Expenses | 266.36M | 302.56M | 281.49M | 254.27M | 323.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.53M | 14.31M | 11.79M | 11.63M | 11.78M |
| Total Finance Division Other Current Liabilities | 35.00M | -- | -- | 304.00K | -- |
| Total Other Current Liabilities | 35.00M | -- | -- | 304.00K | -- |
| Total Current Liabilities | 332.22M | 361.44M | 305.52M | 277.11M | 356.58M |
|
|
|||||
| Total Current Liabilities | 332.22M | 361.44M | 305.52M | 277.11M | 356.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 57.32M | 59.55M | 39.00M | 40.55M | 43.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.12M | 15.31M | 12.64M | 19.14M | 13.89M |
| Total Liabilities | 406.66M | 436.29M | 357.16M | 336.81M | 413.50M |
|
|
|||||
| Common Stock & APIC | 3.12B | 3.09B | 3.06B | 3.04B | 3.00B |
| Retained Earnings | -1.72B | -1.78B | -1.81B | -1.81B | -2.09B |
| Treasury Stock & Other | -2.94M | -958.00K | -563.00K | 1.45M | 989.00K |
| Total Common Equity | 1.39B | 1.31B | 1.25B | 1.23B | 917.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.39B | 1.31B | 1.25B | 1.23B | 917.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.39B | 1.31B | 1.25B | 1.23B | 917.27M |
|
|
|||||